First human test for new scleroderma drug begins
NCT ID NCT07158996
Summary
This is a very early study to check if a new drug called cizutamig is safe and how it behaves in the body of people with systemic sclerosis. It will involve 10 adults with a specific, more severe form of the disease who haven't responded well to other treatments. The main goal is to understand the drug's safety profile and gather initial clues about its potential effects on the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.